Track Valbiotis SA — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Valbiotis SA ALVAL.PA · Stock Open Valbiotis SA in new tab

0.8560 EUR
Add to portfolio
EPS
-0.46
P/B
2.96
ROE
-108.68
Beta
-0.20
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
EPS-0.46
Book Value0.29
Price to Book2.96
Debt/Equity73.12
% Insiders2.571%
Growth
Revenue Growth3.06%
Estimates
Forward P/E-10.86
Forward EPS-0.08

DCF Valuation

Tweak assumptions to recompute fair value for Valbiotis SA (ALVAL.PA)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Valbiotis SA Logo Valbiotis SA Analysis (ALVAL.PA)

France Health Care Official Website Stock

Is Valbiotis SA a good investment? Valbiotis SA (ALVAL.PA) is currently trading at 0.8560 EUR.

Investor FAQ

Does Valbiotis SA pay a dividend?

No, it does not currently pay a dividend.

What asset class is Valbiotis SA?

Valbiotis SA is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbeing, metabolic and cardiovascular health, and beauty and physical comfort. It also develops TOTUM-63 for the reduction of fasting blood glucose and treatment of type 2 diabetes; TOTUM-854, which is in Phase II/III clinical trials for reducing systolic blood pressure; and TOTUM-448 for the reduction of hepatic steatosis. Additionally, the company offers e-commerce delivery service in Belgium and Luxembourg. Valbiotis SA was incorporated in 2014 and is based in Périgny, France.

Exchange Ticker
PAR (France) ALVAL.PA
FRA (Germany) 8JD.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion